Verastem presents two-year follow-up data for ovarian cancer therapy
Go back to Verastem presents two-year follow-up data for ovarian cancer therapy| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 4.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.21 | 52 Week High | $2.43 | |||
| Open | $4.21 | 52 Week Low | $1.05 | |||
| Day High | $4.21 | P/E | N/A | |||
| Day Low | $4.21 | EPS | $-1.79 | |||
| Volume | 4,679 | |||||

